Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01291836 · ClinicalTrials.gov registry record

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

A clinical trial of Acute Kidney Injury and Acute Decompensated Heart Failure, sponsored by Alere San Diego.

Completed
Registry status
930
Enrollment target
13
Study locations

NCT01291836 is a study of Acute Kidney Injury and Acute Decompensated Heart Failure that has completed, run by Alere San Diego. The registered enrollment target is 930 participants, below the 2,318-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (60% lower). The trial reports 13 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01291836, a study of Acute Kidney Injury and Acute Decompensated Heart Failure, has completed, sponsored by Alere San Diego.

COMPLETED
Registry status
930 participants
Enrollment target
13
Study locations

Study Summary

AKINESIS is a clinical study to assess the utility of blood and urine NGAL tests in predicting worsening kidney function in patients who present with acute heart failure (AHF) and who are treated with diuretics. It is believed that rising NGAL levels in the blood and/or urine can predict acute kidney injury. It is also believed that patients who are admitted to the hospital with high NGAL levels in the blood/urine will have poorer outcomes.

Conditions Studied

Acute Kidney Injury Acute Decompensated Heart Failure

Study Locations (13)

Other

  • Athens University Hospital Attikon - Athens
  • University Hospital Dublin - Dublin
  • Clinica Mediterranea - Naples
  • Monasterio Foundation for Medical Research and Public Health - Pisa
  • Hospital Clínico Universitario Valencia - Valencia

California

  • University of California San Diego Medical Center - San Diego
  • San Diego Veterans Administration Hospital - San Diego

Kansas

  • Kansas University Medical Center - Kansas City

Michigan

  • Henry Ford Health System - Detroit

New York

  • New York Methodist Hospital - Brooklyn

Virginia

  • Virginia Commonweath University Medical Center - Richmond

GZ Groningen

  • University of Groningen Medical Center - Groningen

Petersgraben

  • Universitätsspital Basel - Basel

Trial Details

FieldValue
Enrollment Target 930 participants
Start Date 2010-12
Est. Completion 2015-06

Sponsor

Alere San Diego

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01291836

The ClinicalTrials.gov registry entry for NCT01291836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 930 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,318-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (60% lower). The listed sponsor is Alere San Diego, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.

NCT01291836 reports 13 study locations spanning 8 distinct geographic areas - top geographies include Other, California, Kansas.

Frequently Asked Questions

What is clinical trial NCT01291836 about?

NCT01291836 is a clinical study titled "Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study". AKINESIS is a clinical study to assess the utility of blood and urine NGAL tests in predicting worsening kidney function in patients who present with acute heart failure (AHF) and who are treated with diuretics. It is believed that rising NGAL levels in the blood and/or urine can predict acute kidne...

What is the current status of trial NCT01291836?

This trial is currently completed. The enrollment target is 930 participants. The study started on 2010-12. Estimated completion is 2015-06.

What conditions does trial NCT01291836 study?

This clinical trial studies the following conditions: Acute Kidney Injury, Acute Decompensated Heart Failure.

Who is sponsoring clinical trial NCT01291836?

This trial is sponsored by Alere San Diego, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01291836 being conducted?

This trial has 13 study locations across California, Kansas, Michigan, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Kidney Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Kidney Injury

All registered trials for this condition

Acute Decompensated Heart Failure

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.